Please login to the form below

Not currently logged in
Email:
Password:

Surface Oncology

This page shows the latest Surface Oncology news and features for those working in and with pharma, biotech and healthcare.

GSK signs collaboration deal with Ligand targeting neurological disorders

GSK signs collaboration deal with Ligand targeting neurological disorders

This includes a deal announced last week with Surface Oncology for access to the biotech’s lead preclinical oncology asset. ... GSK paid $85m upfront for Surface’s asset SRF813, a fully human IgG1 antibody targeting PVRIG – an inhibitory protein

Latest news

  • GSK pays $85m upfront for Surface Oncology’s lead cancer drug GSK pays $85m upfront for Surface Oncology’s lead cancer drug

    British pharma company adds preclinical antibody to its pipeline. GlaxoSmithKline (GSK) has added a preclinical oncology asset to its pipeline after paying $85m upfront for Surface Oncology’s lead asset. ... Novartis signed an agreement with Surface

  • Sanofi and Novartis snap up immuno-oncology candidates Sanofi and Novartis snap up immuno-oncology candidates

    Details of the Novartis agreement are sketchy, but the company says it has licensed four preclinical programmes from Massachusetts-based Surface Oncology's portfolio which target "regulatory T cell populations, inhibitory ... The candidates will be

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Menopause-thumbnail.png
Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...